Education
About Us
Working with TipRanks
Follow Us
FibroGen (FGEN)
NASDAQ:FGEN
FGEN Analyst Ratings
Moderate Buy
1 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
FGEN Stock 12 Month Forecast
Average Price Target
$43.00
▲(402.92% Upside)
| Highest Price Target$43.00 | Average Price Target$43.00 | Lowest Price Target$43.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
William Blair
―
Hold
―
Reiterated
11/11/25
FibroGen's Strategic Moves and Financial Outlook: Hold Rating Amid UncertaintiesWe have adjusted our financial model to more accurately reflect current operating trends and management guidance, which is summarized in exhibit 2. A list of upcoming clinical catalysts is summarized in exhibit 3. Stock Thoughts. We are encouraged by initial results generated from the FG-3246 program, which targets CD46, and we look forward to continued progress on FG-3246 in mCRPC in the pre-chemotherapy stage, as well as from roxadustat in LR-MDS. Given the early stage of the highly competitive prostate cancer market, we believe it is prudent to wait for additional data (such as the upcoming combination data likely at ASCO- GU and the initial monotherapy results expected in the second half of 2026) prior to drawing solid conclusions. We therefore reiterate our Market Perform rating on FibroGen shares.
H.C. Wainwright
$10→$43
Buy
402.92%
Upside
Reiterated
11/11/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
William Blair
―
Hold
―
Reiterated
11/11/25
FibroGen's Strategic Moves and Financial Outlook: Hold Rating Amid UncertaintiesWe have adjusted our financial model to more accurately reflect current operating trends and management guidance, which is summarized in exhibit 2. A list of upcoming clinical catalysts is summarized in exhibit 3. Stock Thoughts. We are encouraged by initial results generated from the FG-3246 program, which targets CD46, and we look forward to continued progress on FG-3246 in mCRPC in the pre-chemotherapy stage, as well as from roxadustat in LR-MDS. Given the early stage of the highly competitive prostate cancer market, we believe it is prudent to wait for additional data (such as the upcoming combination data likely at ASCO- GU and the initial monotherapy results expected in the second half of 2026) prior to drawing solid conclusions. We therefore reiterate our Market Perform rating on FibroGen shares.
H.C. Wainwright
$10→$43
Buy
402.92%
Upside
Reiterated
11/11/25
Best Analysts Covering FibroGen
1 Month
xxx
Success Rate
2/7 ratings generated profit
Average Return
+2.69%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 28.57% of your transactions generating a profit, with an average return of +2.69% per trade.
3 Months
xxx
Success Rate
3/7 ratings generated profit
Average Return
-8.39%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of -8.39% per trade.
1 Year
Success Rate
4/7 ratings generated profit
Average Return
-4.89%
reiterated a buy rating 10 days ago
Copying Matthew Keller's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of -4.89% per trade.
2 Years
xxx
Success Rate
4/7 ratings generated profit
Average Return
-4.89%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 57.14% of your transactions generating a profit, with an average return of -4.89% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
FGEN Analyst Recommendation Trends
Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
1
2
5
5
4
Buy
0
0
0
0
0
Hold
13
15
16
12
10
Sell
1
1
0
0
0
Strong Sell
0
0
0
0
0
total
15
18
21
17
14
Each month's total comprises the sum of three months' worth of ratings.
FGEN Financial Forecast
FGEN Stock Forecast FAQ
What is FGEN’s average 12-month price target, according to analysts?
Based on analyst ratings, FibroGen’s 12-month average price target is 43.00.
What is FGEN’s upside potential, based on the analysts’ average price target?
FibroGen has 402.92% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is FGEN a Buy, Sell or Hold?
FibroGen has a consensus rating of Moderate Buy which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
What is FibroGen’s price target?
The average price target for FibroGen is 43.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $43.00 ,the lowest forecast is $43.00. The average price target represents 402.92% Increase from the current price of $8.55.
The highest analyst price target is $43.00 ,the lowest forecast is $43.00. The average price target represents 402.92% Increase from the current price of $8.55.
What do analysts say about FibroGen?
FibroGen’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of FGEN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.